Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levulan PDT for Actinic Keratosis
NCT01475955Phase 2Completed
- Sponsor
- DUSA Pharmaceuticals
- Start
- Dec 2011
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aminolevulinic acid in actinic keratosis (AK), sponsored by DUSA Pharmaceuticals. Started Dec 2011; status: completed.
02
Drugs
aminolevulinic acid
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT01475955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01475955.